Annual FCF
-$61.04 M
-$14.05 M-29.91%
31 March 2022
Summary:
Sio Gene Therapies annual free cash flow is currently -$61.04 million, with the most recent change of -$14.05 million (-29.91%) on 31 March 2022. During the last 3 years, it has fallen by -$14.05 million (-29.91%).SIOX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$4.92 M
+$174.00 K+3.41%
31 December 2022
Summary:
Sio Gene Therapies quarterly free cash flow is currently -$4.92 million, with the most recent change of +$174.00 thousand (+3.41%) on 31 December 2022.SIOX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$37.16 M
+$15.82 M+29.87%
31 December 2022
Summary:
Sio Gene Therapies TTM free cash flow is currently -$37.16 million, with the most recent change of +$15.82 million (+29.87%) on 31 December 2022.SIOX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -29.9% | +76.3% | +30.2% |
| 5 y5 years | +54.6% | +62.6% | +39.6% |
SIOX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +29.9% | +8.4% | +718.1% |
Sio Gene Therapies Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | - | -$4.92 M(-3.4%) | -$37.16 M(-29.9%) |
| Sept 2022 | - | -$5.10 M(-43.1%) | -$52.98 M(-7.3%) |
| June 2022 | - | -$8.96 M(-50.7%) | -$57.17 M(-6.3%) |
| Mar 2022 | -$61.04 M(+29.9%) | -$18.18 M(-12.4%) | -$61.04 M(+14.6%) |
| Dec 2021 | - | -$20.75 M(+123.5%) | -$53.25 M(+22.0%) |
| Sept 2021 | - | -$9.28 M(-27.7%) | -$43.65 M(-5.7%) |
| June 2021 | - | -$12.83 M(+23.5%) | -$46.30 M(-1.5%) |
| Mar 2021 | -$46.99 M(-30.6%) | -$10.39 M(-6.7%) | -$46.99 M(-13.8%) |
| Dec 2020 | - | -$11.14 M(-6.6%) | -$54.51 M(-3.6%) |
| Sept 2020 | - | -$11.93 M(-11.8%) | -$56.53 M(-10.9%) |
| June 2020 | - | -$13.52 M(-24.5%) | -$63.44 M(-6.3%) |
| Mar 2020 | -$67.73 M(-49.6%) | -$17.91 M(+36.1%) | -$67.73 M(+10.1%) |
| Dec 2019 | - | -$13.16 M(-30.1%) | -$61.52 M(-24.9%) |
| Sept 2019 | - | -$18.84 M(+5.8%) | -$81.89 M(-9.8%) |
| June 2019 | - | -$17.81 M(+52.1%) | -$90.81 M(-32.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | -$134.41 M(-30.9%) | -$11.71 M(-65.1%) | -$134.41 M(-14.4%) |
| Dec 2018 | - | -$33.53 M(+20.8%) | -$156.94 M(-8.0%) |
| Sept 2018 | - | -$27.75 M(-54.8%) | -$170.60 M(-17.2%) |
| June 2018 | - | -$61.41 M(+79.4%) | -$205.96 M(+5.8%) |
| Mar 2018 | -$194.63 M(+73.4%) | -$34.24 M(-27.5%) | -$194.63 M(-3.5%) |
| Dec 2017 | - | -$47.19 M(-25.2%) | -$201.75 M(+9.8%) |
| Sept 2017 | - | -$63.11 M(+26.0%) | -$183.82 M(+27.9%) |
| June 2017 | - | -$50.09 M(+21.1%) | -$143.71 M(+28.1%) |
| Mar 2017 | -$112.21 M(+91.2%) | -$41.36 M(+41.4%) | -$112.21 M(+18.6%) |
| Dec 2016 | - | -$29.26 M(+27.2%) | -$94.60 M(+10.6%) |
| Sept 2016 | - | -$23.00 M(+23.7%) | -$85.56 M(+17.6%) |
| June 2016 | - | -$18.59 M(-21.7%) | -$72.75 M(+23.9%) |
| Mar 2016 | -$58.69 M | -$23.75 M(+17.5%) | -$58.69 M(+68.0%) |
| Dec 2015 | - | -$20.21 M(+98.3%) | -$34.95 M(+137.2%) |
| Sept 2015 | - | -$10.19 M(+124.4%) | -$14.73 M(+224.4%) |
| June 2015 | - | -$4.54 M | -$4.54 M |
FAQ
- What is Sio Gene Therapies annual free cash flow?
- What is the all time high annual FCF for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly free cash flow?
- What is the all time high quarterly FCF for Sio Gene Therapies?
- What is Sio Gene Therapies TTM free cash flow?
- What is the all time high TTM FCF for Sio Gene Therapies?
What is Sio Gene Therapies annual free cash flow?
The current annual FCF of SIOX is -$61.04 M
What is the all time high annual FCF for Sio Gene Therapies?
Sio Gene Therapies all-time high annual free cash flow is -$46.99 M
What is Sio Gene Therapies quarterly free cash flow?
The current quarterly FCF of SIOX is -$4.92 M
What is the all time high quarterly FCF for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly free cash flow is -$4.54 M
What is Sio Gene Therapies TTM free cash flow?
The current TTM FCF of SIOX is -$37.16 M
What is the all time high TTM FCF for Sio Gene Therapies?
Sio Gene Therapies all-time high TTM free cash flow is -$4.54 M